NOVARTIND vs PARKHOSPS: Stock Comparison
Park Medi World Ltd is the larger company by market capitalisation. Novartis India Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Park Medi World Ltd shows a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
NOVARTIND leads 8; PARKHOSPS leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NOVARTIND | PARKHOSPS |
|---|---|---|
| Sector | Healthcare | — |
| Industry | Pharmaceuticals | — |
Price
| Metric | NOVARTIND | PARKHOSPS |
|---|---|---|
| Live Price | ₹1,486.3 | ₹284.05 |
| Day Change | -1.06% | 1.43% |
| Volume | 6,845 | 6.94 L |
| 52-Week High | ₹1,780 | ₹305 |
| 52-Week Low | ₹950 | ₹138.1 |
| Distance from 52W High | -16.5% | -6.87% |
Valuation
| Metric | NOVARTIND | PARKHOSPS |
|---|---|---|
| Market Cap | ₹3,664 Cr | ₹12,282 Cr |
| P/E Ratio | 37.65x | 46.91x |
| P/B Ratio | 4.5x | 5.99x |
| EPS | ₹37.76 | ₹5.98 |
| Book Value | ₹331.34 | ₹46.8 |
| Dividend Yield | 1.7% | 0% |
Growth
| Metric | NOVARTIND | PARKHOSPS |
|---|---|---|
| Revenue Growth (TTM YoY) | 8% | 0% |
| EPS Growth (TTM YoY) | -13.8% | 0% |
| Qtr Sales Growth | 7.95% | 30.1% |
| Qtr Profit Growth | -13.8% | 58% |
Profitability & Leverage
| Metric | NOVARTIND | PARKHOSPS |
|---|---|---|
| ROE | 11.6% | 16.7% |
| ROCE | 16.2% | 19.3% |
| Net Margin | 26.3% | 16.29% |
| Operating Margin | 26.6% | 26.5% |
| Debt to Equity | 0x | 0.18x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | NOVARTIND | PARKHOSPS |
|---|---|---|
| Promoter Holding | 0% | 82.89% |
| FII Holding | 0.16%▼ 0.01 pp | 0.82%▼ 0.04 pp |
| DII Holding | 1.36%▲ 0.83 pp | 8.95%▼ 0.3 pp |
| Public Holding | 27.8%▼ 0.81 pp | 7.33%▲ 0.34 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Novartis India Limited and Park Medi World Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.